Biotech entity

Medicinal Cannabis

Product

pharma is the sole category represented across all 2 tracked stories. Bilal Cassim is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 12-day window averages about 1.2 stories each week. Source depth averages 2 original sources per story, versus 3.6 across the same-window beat baseline.

Last mentioned: Mar 9, 2026

Entity pulse

Recent coverage · Medicinal Cannabis

2 stories
5.5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Medicinal Cannabis

pharma is the sole category represented across all 2 tracked stories. Bilal Cassim is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. The 12-day window averages about 1.2 stories each week. Source depth averages 2 original sources per story, versus 3.6 across the same-window beat baseline. The 5.5 average consequence score is below the beat benchmark of 6.1 in the same window. This profile follows 2 Biotech stories mentioning Medicinal Cannabis across the period from March 9, 2026 to March 20, 2026.

Stories tracked
2
Per week
1.2
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 192 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Medicinal Cannabis. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Medicinal Cannabis 2

Pharma Neutral

Patient Advocacy Signals Growth in Medicinal Cannabis for PTSD Treatment

Bilal Cassim’s public testimony regarding the efficacy of medicinal cannabis for PTSD and sleep disorders highlights a growing trend of patient-led advocacy in Australia. This case underscores the shifting clinical landscape as researchers and regulators grapple with the integration of cannabinoid therapies into standard psychiatric care.

2 sources
Pharma Neutral

NSW Signals Landmark Shift in Medicinal Cannabis Driving Regulations

The New South Wales Government has signaled a major policy shift by proposing to legalize driving for medicinal cannabis users who have THC in their system. This move aims to transition from a zero-tolerance 'presence' model to an 'impairment-based' framework for legal patients.

2 sources

Medicinal Cannabis is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.